Daliresp
Daliresp is a asthma respiratory medication containing Roflumilast, available as 500mg tablets.
- Category
- Asthma Respiratory
- Active ingredient
- Roflumilast
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 500mg
Prescription rules on Daliresp vary by country.
Details
- Conditions
- Chronic obstructive pulmonary disease
- Alternative Name
- Daxas
- Therapeutic Class
- Phosphodiesterase-4 Inhibitor
- Pharmacological Class
- PDE4 Inhibitor
- Minor Side Effects
- diarrhoea, nausea, weight loss, abdominal pain
- Moderate Side Effects
- headache, insomnia, anxiety
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Manufacturer
- AstraZeneca
- Onset Time
- 2–4 weeks
- Duration
- 24 hours
- Storage Instructions
- Store at room temperature in a dry place.
- Drug Interactions
- rifampicin, phenobarbital, carbamazepine, phenytoin
- Age Restrictions
- Not for use in those under 18 years.